Teleflex Incorporated

NYSE TFX

Teleflex Incorporated Free Cash Flow for the Trailing 12 Months (TTM) ending September 29, 2024: USD 450.04 M

Teleflex Incorporated Free Cash Flow is USD 450.04 M for the Trailing 12 Months (TTM) ending September 29, 2024, a 18.53% change year over year. Free cash flow is the amount of cash a company generates after accounting for cash outflows to support operations and maintain its capital assets.
  • Teleflex Incorporated Free Cash Flow for the Trailing 12 Months (TTM) ending October 01, 2023 was USD 379.68 M, a 1.63% change year over year.
  • Teleflex Incorporated Free Cash Flow for the Trailing 12 Months (TTM) ending September 25, 2022 was USD 373.60 M, a -33.87% change year over year.
  • Teleflex Incorporated Free Cash Flow for the Trailing 12 Months (TTM) ending September 26, 2021 was USD 564.98 M, a 83.80% change year over year.
  • Teleflex Incorporated Free Cash Flow for the Trailing 12 Months (TTM) ending September 27, 2020 was USD 307.39 M, a -3.37% change year over year.
Key data
Date Free Cash Flow Operating Cash Flow Net Cash Used For Investing Activities Net Cash Used Provided By Financing Activities
Market news
Loading...
NYSE: TFX

Teleflex Incorporated

CEO Mr. Liam J. Kelly
IPO Date March 17, 1980
Location United States
Headquarters 550 East Swedesford Road
Employees 14,500
Sector Health Care
Industries
Description

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site. The company also offers interventional products, which consists of various coronary catheters, structural heart therapies, and peripheral intervention and cardiac assist products that are used by interventional cardiologists and radiologists, and vascular surgeons; and Arrow branded catheters, Guideline and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices. It provides anesthesia products, such as airway and pain management products to support hospital, emergency medicine, and military channels; and surgical products, including metal and polymer ligation clips, and fascial closure surgical systems that are used in laparoscopic surgical procedures, percutaneous surgical systems, and other surgical instruments. The company also offers interventional urology products comprising the UroLift System, an invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia; and respiratory products, including oxygen and aerosol therapies, spirometry, and ventilation management products for use in various care settings. It provides urology products, such as catheters, urine collectors, and catheterization accessories and products for operative endourology; and bladder management services. The company serves hospitals and healthcare providers, medical device manufacturers, and home care markets. The company was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.

Similar companies

HAE

Haemonetics Corporation

USD 79.96

0.69%

NVST

Envista Holdings Corp

USD 18.85

-0.74%

ATR

AptarGroup, Inc.

USD 154.61

0.47%

COO

The Cooper Companies, Inc.

USD 89.11

-2.38%

WST

West Pharmaceutical Services, Inc.

USD 328.96

-3.13%

BDX

Becton, Dickinson and Company

USD 235.80

-0.17%

RMD

ResMed Inc.

USD 228.83

-0.62%

MMSI

Merit Medical Systems, Inc.

USD 99.89

4.44%

ICUI

ICU Medical, Inc.

USD 161.08

1.85%

HOLX

Hologic, Inc.

USD 70.20

-0.13%

ANGO

AngioDynamics, Inc.

USD 11.80

-5.30%

StockViz Staff

January 15, 2025

Any question? Send us an email